TP53 mutation profile in chronic lymphocytic leukemia: evidence for a disease specific profile from a comprehensive analysis of 268 mutations
Zenz, T, Vollmer, D, Trbusek, M, Smardova, J, Benner, A, Soussi, T, Helfrich, H, Heuberger, M, Hoth, P, Fuge, M, Denzel, T, Häbe, S, Malcikova, J, Kuglik, P, Truong, S, Patten, N, Wu, L, Oscier, D, Ibbotson, R, Gardiner, A, Tracy, I, Lin, K, Pettitt, A, Pospisilova, S, Mayer, J, Hallek, M, Döhner, H, Stilgenbauer, S
Published in Leukemia (01.12.2010)
Published in Leukemia (01.12.2010)
Get full text
Journal Article
Alterations in regulatory T cells and immune checkpoint molecules in pancreatic cancer patients receiving FOLFIRINOX or gemcitabine plus nab-paclitaxel
Sams, L., Kruger, S., Heinemann, V., Bararia, D., Haebe, S., Alig, S., Haas, M., Zhang, D., Westphalen, C. B., Ormanns, S., Metzger, P., Werner, J., Weigert, O., von Bergwelt-Baildon, M., Rataj, F., Kobold, S., Boeck, S.
Published in Clinical & translational oncology (01.11.2021)
Published in Clinical & translational oncology (01.11.2021)
Get full text
Journal Article
Alterations in peripheral T cell subsets, T cell activation markers and immune checkpoint molecules in advanced pancreatic cancer patients receiving FOLFIRINOX or gemcitabine + nab-paclitaxel
Sams, L.E., Kruger, S., Heinemann, V., Bararia, D., Haebe, S., Alig, S., Westphalen, B., Haas, M., Kirchner, T., Ormanns, S., Endres, S., Weigert, O., von Bergwelt-Baildon, M., Kobold, S., Rataj, F., Boeck, S.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
1195PAlterations in peripheral T cell subsets, T cell activation markers and immune checkpoint molecules in advanced pancreatic cancer patients receiving FOLFIRINOX or gemcitabine + nab-paclitaxel
Sams, L E, Kruger, S, Heinemann, V, Bararia, D, Haebe, S, Alig, S, Westphalen, B, Haas, M, Kirchner, T, Ormanns, S, Endres, S, Weigert, O, von Bergwelt-Baildon, M, Kobold, S, Rataj, F, Boeck, S
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
How little is too much? p53 inactivation: from laboratory cutoff to biological basis of chemotherapy resistance
Zenz, T, Häbe, S, Denzel, T, Winkler, D, Döhner, H, Stilgenbauer, S
Published in Leukemia (01.12.2008)
Published in Leukemia (01.12.2008)
Get full text
Journal Article
TCL1A and ATM are co-expressed in chronic lymphocytic leukemia cells without deletion of 11q
Garding, Angela, Bhattacharya, Nupur, Haebe, Sarah, Müller, Frederike, Weichenhan, Dieter, Idler, Irina, Ickstadt, Katja, Stilgenbauer, Stephan, Mertens, Daniel
Published in Haematologica (Roma) (01.02.2013)
Published in Haematologica (Roma) (01.02.2013)
Get full text
Journal Article